{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:07:30Z","timestamp":1786421250129,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jhepr.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T19:31:19Z","timestamp":1572031879000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["KIR\/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis"],"prefix":"10.1016","volume":"1","author":[{"given":"Takeji","family":"Umemura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Joshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaname","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2019.09.003_bb0005","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0010","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.autrev.2018.02.013","article-title":"Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers","volume":"17","author":"Bossen","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100565","article-title":"Human leukocyte antigen class II haplotypes affect clinical characteristics and progression of type 1 autoimmune hepatitis in Japan","volume":"9","author":"Umemura","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0020","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0025","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0198-8859(94)90008-6","article-title":"Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype","volume":"41","author":"Fainboim","year":"1994","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0030","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ni1582","article-title":"Functions of natural killer cells","volume":"9","author":"Vivier","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hep4.1163","article-title":"Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis","volume":"2","author":"Jeffery","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clim.2017.12.004","article-title":"Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis","volume":"188","author":"Mele","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0045","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cellimm.2017.12.008","article-title":"Intrahepatic recruitment of cytotoxic NK cells contributes to autoimmune hepatitis progression","volume":"327","author":"Xiao","year":"2018","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3799","article-title":"Balancing natural killer cell activation through paired receptors","volume":"15","author":"Martinet","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0055","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0060","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1073\/pnas.90.24.12000","article-title":"HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells","volume":"90","author":"Colonna","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0065","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.180.4.1235","article-title":"NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80","volume":"180","author":"Cella","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0070","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.4049\/jimmunol.156.9.3098","article-title":"A human killer inhibitory receptor specific for HLA-A1,2","volume":"156","author":"D\u00f6hring","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0075","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/eji.200425089","article-title":"Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific","volume":"34","author":"Hansasuta","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146086","article-title":"Exploring the Role of Killer Cell Immunoglobulin-Like Receptors and Their HLA Class I Ligands in Autoimmune Hepatitis","volume":"11","author":"Littera","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/gene.2016.7","article-title":"The early onset of type 1 autoimmune hepatitis has a strong genetic influence: role of HLA and KIR genes","volume":"17","author":"Podhorzer","year":"2016","journal-title":"Genes Immun"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0090","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1034\/j.1399-0039.2000.560606.x","article-title":"Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population","volume":"56","author":"Saito","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0095","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.21700","article-title":"Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis","volume":"46","author":"Umemura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0105","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/hep.25658","article-title":"Long-term outcome of Japanese patients with type 1 autoimmune hepatitis","volume":"56","author":"Yoshizawa","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0110","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: Autoimmune hepatitis","volume":"63","author":"European Association for the Study of the L","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0115","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2012.09.009","article-title":"Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission","volume":"58","author":"van Gerven","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0120","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.24705","article-title":"Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis","volume":"55","author":"Umemura","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02421207","article-title":"Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6","volume":"30","author":"Muller","year":"1989","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng934","article-title":"Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS","volume":"31","author":"Martin","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0135","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.18632\/oncotarget.24752","article-title":"KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients","volume":"9","author":"Saito","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187325","article-title":"HLA-DRB1 and DQB1 alleles in Japanese type 1 autoimmune hepatitis: The predisposing role of the DR4\/DR8 heterozygous genotype","volume":"12","author":"Oka","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/1756-0500-2-105","article-title":"The synergy factor: a statistic to measure interactions in complex diseases","volume":"2","author":"Cortina-Borja","year":"2009","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood-2008-01-132902","article-title":"The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations","volume":"112","author":"Foley","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0160","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2017.03.040","article-title":"HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs","volume":"67","author":"Thons","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0165","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/eji.1830270231","article-title":"Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains","volume":"27","author":"Rojo","year":"1997","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195778","article-title":"Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population","volume":"13","author":"Saito","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0175","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1007\/s10620-015-3699-4","article-title":"Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease","volume":"60","author":"DeFilippis","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0180","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0185","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0190","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","article-title":"Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function","volume":"203","author":"Yawata","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0195","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1172\/JCI98463","article-title":"Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1","volume":"128","author":"Martin","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0200","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0205","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.jhep.2009.01.020","article-title":"Autoimmune hepatitis in Italy: the Bologna experience","volume":"50","author":"Muratori","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0210","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2019.09.003_bb0215","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cgh.2018.09.046","article-title":"Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune Hepatitis","volume":"17","author":"van den Brand","year":"2019","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555919301089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555919301089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:22:48Z","timestamp":1762899768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555919301089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2589555919301089"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2019.09.003","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KIR\/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}]}}